{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:31:43Z","timestamp":1781703103815,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ando.2017.01.002","type":"journal-article","created":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T14:01:49Z","timestamp":1497621709000},"page":"156-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical follow-up of the first SF-1 insufficient female patient"],"prefix":"10.1016","volume":"78","author":[{"given":"Karine","family":"Gerster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Biason-Lauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen J.","family":"Schoenle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2017.01.002_bib0175","doi-asserted-by":"crossref","first-page":"17913","DOI":"10.1016\/S0021-9258(19)37129-7","article-title":"A common trans-acting factor, Ad4-binding protein, to the promoters of steroidogenic P-450s","volume":"267","author":"Morohashi","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ando.2017.01.002_bib0180","first-page":"1249","article-title":"Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I","volume":"6","author":"Lala","year":"1992","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ando.2017.01.002_bib0185","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1210\/edrv.18.3.0301","article-title":"Steroidogenic factor 1: a key determinant of endocrine development and function","volume":"18","author":"Parker","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2017.01.002_bib0190","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000152036","article-title":"Steroidogenic factor-1 (SF-1, Ad4BP, NR5A1) and disorders of testis development","volume":"2","author":"Lin","year":"2008","journal-title":"Sex Dev"},{"key":"10.1016\/j.ando.2017.01.002_bib0195","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.mce.2010.11.006","article-title":"Steroidogenic factor-1 (SF-1, NR5A1) and human disease","volume":"336","author":"Ferraz-de-Souza","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ando.2017.01.002_bib0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0925-4773(99)00123-9","article-title":"Expression of steroidogenic factor 1 and Wilms\u2019 tumour 1 during early human gonadal development and sex determination","volume":"87","author":"Hanley","year":"1999","journal-title":"Mech Dev"},{"key":"10.1016\/j.ando.2017.01.002_bib0205","first-page":"2815","article-title":"Immunohistochemical localization of Ad4-binding protein with correlation to steroidogenic enzyme expression in cycling human ovaries and sex cord stromal tumors","volume":"80","author":"Takayama","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2017.01.002_bib0210","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0092-8674(94)90211-9","article-title":"A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation","volume":"77","author":"Luo","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.ando.2017.01.002_bib0215","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/aja.1002040104","article-title":"Developmental defects of the ventromedial hypothalamic nucleus and pituitary gonadotroph in the Ftz-F1 disrupted mice","volume":"204","author":"Shinoda","year":"1995","journal-title":"Dev Dyn"},{"key":"10.1016\/j.ando.2017.01.002_bib0220","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1210\/endo.143.2.8652","article-title":"Knockout mice lacking steroidogenic factor 1 are a novel genetic model of hypothalamic obesity","volume":"143","author":"Majdic","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.ando.2017.01.002_bib0225","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/9629","article-title":"A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans","volume":"22","author":"Achermann","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.ando.2017.01.002_bib0230","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1210\/jcem.87.4.8376","article-title":"Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner","volume":"87","author":"Achermann","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2017.01.002_bib0235","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1210\/jc.2006-0603","article-title":"Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years\u2019 experience","volume":"91","author":"Lin","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2017.01.002_bib0240","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1210\/jc.2015-3250","article-title":"Rare causes of primary adrenal insufficiency: genetic and clinical characterization of a large nationwide cohort","volume":"101","author":"Guran","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2017.01.002_bib0245","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1210\/me.2003-0404","article-title":"Cell-specific knockout of steroidogenic factor 1 reveals its essential roles in gonadal function","volume":"18","author":"Jeyasuria","year":"2004","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ando.2017.01.002_bib0250","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa0806228","article-title":"Mutations in NR5A1 associated with ovarian insufficiency","volume":"360","author":"Lourenco","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2017.01.002_bib0255","doi-asserted-by":"crossref","first-page":"141e2","DOI":"10.1016\/j.fertnstert.2011.10.032","article-title":"Limited contribution of NR5A1 (SF-1) mutations in women with primary ovarian insufficiency (POI)","volume":"97","author":"Janse","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ando.2017.01.002_bib0260","doi-asserted-by":"crossref","first-page":"E1017","DOI":"10.1210\/jc.2012-4111","article-title":"NR5A1 (SF-1) mutations are not a major cause of primary ovarian insufficiency","volume":"98","author":"Voican","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2017.01.002_bib0265","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1086\/316893","article-title":"Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1\/SF-1) and adrenocortical insufficiency","volume":"67","author":"Biason-Lauber","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ando.2017.01.002_bib0270","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1095\/biolreprod.108.069435","article-title":"Impaired follicle development and infertility in female mice lacking steroidogenic factor 1 in ovarian granulosa cells","volume":"79","author":"Pelusi","year":"2008","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ando.2017.01.002_bib0275","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.fertnstert.2012.10.026","article-title":"NR5A1 (SF-1) gene variants in a group of 26 young women with XX primary ovarian insufficiency","volume":"99","author":"Philibert","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ando.2017.01.002_bib0280","article-title":"Identical NR5A1 missense mutations in two unrelated 46, XX individuals with testicular tissues","author":"Igarashi","year":"2016","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ando.2017.01.002_bib0285","article-title":"NR5A1 is a novel disease gene for 46, XX testicular and ovotesticular disorders of sex development","author":"Baetens","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.ando.2017.01.002_bib0290","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1093\/humrep\/dem278","article-title":"Mutational analysis of steroidogenic factor 1 (NR5a1) in 24 boys with bilateral anorchia: a French collaborative study","volume":"22","author":"Philibert","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ando.2017.01.002_bib0295","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1210\/jc.2006-1672","article-title":"Heterozygous missense mutations in steroidogenic factor 1 (SF1\/Ad4BP, NR5A1) are associated with 46, XY disorders of sex development with normal adrenal function","volume":"92","author":"Lin","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2017.01.002_bib0300","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000320029","article-title":"Three new SF-1 (NR5A1) gene mutations in two unrelated families with multiple affected members: within-family variability in 46, XY subjects and low ovarian reserve in fertile 46, XX subjects","volume":"75","author":"Warman","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.ando.2017.01.002_bib0305","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1210\/jc.2007-0024","article-title":"Heterozygous mutation of steroidogenic factor-1 in 46, XY subjects may mimic partial androgen insensitivity syndrome","volume":"92","author":"Coutant","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2017.01.002_bib0310","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/humu.20588","article-title":"Five novel mutations in steroidogenic factor 1 (SF1, NR5A1) in 46, XY patients with severe underandrogenization but without adrenal insufficiency","volume":"29","author":"K\u00f6hler","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ando.2017.01.002_bib0315","doi-asserted-by":"crossref","first-page":"E1294","DOI":"10.1210\/jc.2011-3169","article-title":"Ten novel mutations in the NR5A1 gene cause disordered sex development in 46, XY and ovarian insufficiency in 46, XX individuals","volume":"97","author":"Camats","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2017.01.002_bib0320","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000338346","article-title":"Preserved fertility in a patient with a 46, XY disorder of sex development due to a new heterozygous mutation in the NR5A1\/SF-1 gene: evidence of 46, XY and 46, XX gonadal dysgenesis phenotype variability in multiple members of an affected kindred","volume":"78","author":"Ciaccio","year":"2012","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.ando.2017.01.002_bib0325","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/ajmg.a.36084","article-title":"Screening and familial characterization of copy-number variations in NR5A1 in 46, XY disorders of sex development and premature ovarian failure","volume":"161A","author":"Harrison","year":"2013","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ando.2017.01.002_bib0330","doi-asserted-by":"crossref","first-page":"e74759","DOI":"10.1371\/journal.pone.0074759","article-title":"Novel NR5A1 missense mutation in premature ovarian failure: detection in Han Chinese indicates causation in different ethnic groups","volume":"8","author":"Jiao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ando.2017.01.002_bib0335","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/cen.12054","article-title":"A report of two novel NR5A1 mutation families: possible clinical phenotype of psychiatric symptoms of anxiety and\/or depression","volume":"78","author":"Suwanai","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2017.01.002_bib0340","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2350-15-7","article-title":"The novel p.Cys65Tyr mutation in NR5A1 gene in three 46, XY siblings with normal testosterone levels and their mother with primary ovarian insufficiency","volume":"10","author":"Fabbri","year":"2014","journal-title":"BMC Med Genet"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426617300185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426617300185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:50:06Z","timestamp":1757717406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426617300185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0003426617300185"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2017.01.002","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical follow-up of the first SF-1 insufficient female patient","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2017.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}